Amgen (AMGN) and Pfizer (PFE) could soon be snacking on Novo Nordisk (NVO) and Eli Lilly's (LLY) lunch in the anti-obesity market
https://seekingalpha.com/news/3977415-novo-nordisk-lilly-facing-increased-competition-in-obesity-drug-market?source=feed_sector_healthcare
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.